Rate My Professor David Vock

David Vock, PhD, is a Professor in the Division of Biostatistics and Health Data Science at the University of Minnesota Twin Cities School of Public Health. He received his PhD in Statistics from North Carolina State University in 2012, an MStat in Statistics from North Carolina State University in 2009, and a BA in Mathematics and Chemistry summa cum laude from St. Olaf College in 2007. Vock began his academic career at the University of Minnesota as an Assistant Professor in 2012, was promoted to Associate Professor with tenure in 2019, and currently serves as Professor. Prior to this, he held research and teaching assistant positions at North Carolina State University from 2008 to 2012 and interned at the Duke Clinical Research Institute.

His research focuses on two major areas: statistical methods development for electronic health data, with emphasis on machine learning techniques to handle censored data, and novel methods for causal inference and estimation of dynamic treatment regimes, including clinical trial designs such as SMART studies. Vock collaborates on projects related to kidney and liver transplantation, smoking cessation, cardiovascular disease, pediatric obesity, and infectious diseases. Key publications include 'Consequences of low estimated glomerular filtration rate either before or early after kidney donation' (American Journal of Transplantation, 2024, with M.D. Evans et al.); 'The landscape of liver transplantation for patients with Alcohol-associated liver disease in USA' (Liver Transplantation, 2024, with D.M. Vock et al.); 'Transportability of causal inference under random dynamic treatment regimes for kidney-pancreas transplantation' (Biometrics, 2023, with G.R. Lyden et al.); 'The Minnesota attributable risk of kidney donation (MARKD) study' (BMC Nephrology, 2023, with D.M. Vock et al.); 'Rapid discontinuation of prednisone in kidney transplant recipients from at-risk subgroups' (Transplant International, 2020, with D.M. Vock and A.J. Matas); and 'Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus' (Gastroenterology, 2010, with A.J. Thompson et al.). Vock has earned the McKnight Presidential Fellowship (2019), Leonard Schuman Award for Excellence in Teaching (2019), election to Delta Omega (2018) and Sigma Xi (2024) honor societies, and the Thomas R. Ten Have Award (2012). He serves as Statistical Editor for the American Journal of Transplantation (2021-2024), chairs Data and Safety Monitoring Boards for trials including SAVE O2 and FLUX, and contributes to advisory roles for the Scientific Registry of Transplant Recipients.